Position in ZTS
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$370,079
-$161,274 QoQ
Shares Held
5,150
+14.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#860
of 1,408 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MITCHELL SINKLER & STARR/PA holds $611,193 across 2 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (60.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
5,150 | $370,079 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
445 | $241,114 |
All Filings in ZTS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $370,079 | 5,150 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $531,353 | 4,495 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $542,913 | 4,315 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $310,930 | 2,125 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $312,679 | 2,005 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $313,658 | 1,905 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $455,552 | 2,796 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $582,427 | 2,981 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $535,855 | 3,091 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $416,595 | 2,462 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $506,056 | 2,564 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $342,566 | 1,969 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $308,255 | 1,790 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $297,927 | 1,790 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||